BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6352483)

  • 1. Influence of yohimbine on blood pressure, autonomic reflexes, and plasma catecholamines in humans.
    Goldberg MR; Hollister AS; Robertson D
    Hypertension; 1983; 5(5):772-8. PubMed ID: 6352483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alpha 2-adrenergic receptor antagonist yohimbine inhibits epinephrine-induced platelet aggregation in healthy subjects.
    Berlin I; Crespo-Laumonnier B; Cournot A; Landault C; Aubin F; Legrand JC; Puech AJ
    Clin Pharmacol Ther; 1991 Apr; 49(4):362-9. PubMed ID: 2015726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of alpha 2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system.
    Robertson D; Goldberg MR; Tung CS; Hollister AS; Robertson RM
    J Clin Invest; 1986 Aug; 78(2):576-81. PubMed ID: 3734105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone augments muscle sympathetic nerve activity during isometric exercise in humans.
    Farrell PA; Ebert TJ; Kampine JP
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E379-88. PubMed ID: 2003591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of yohimbine, an alpha 2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotension.
    Verwaerde P; Tran MA; Montastruc JL; Senard JM; Portolan G
    Fundam Clin Pharmacol; 1997; 11(6):567-75. PubMed ID: 9444525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous yohimbine. Selective enhancer of norepinephrine and cortisol secretion and systolic blood pressure in humans.
    Grunhaus L; Tiongco D; Zelnik T; Flegel P; Hollingsworth PJ; Smith CB
    Clin Neuropharmacol; 1989 Apr; 12(2):106-14. PubMed ID: 2541903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of yohimbine on human sympathetic nervous system function.
    Murburg MM; Villacres EC; Ko GN; Veith RC
    J Clin Endocrinol Metab; 1991 Oct; 73(4):861-5. PubMed ID: 1890156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls.
    Gurguis GN; Vitton BJ; Uhde TW
    Psychiatry Res; 1997 Jun; 71(1):27-39. PubMed ID: 9247979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
    Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D
    J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure.
    Biaggioni I; Robertson RM; Robertson D
    J Clin Pharmacol; 1994 May; 34(5):418-23. PubMed ID: 8089252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of norepinephrine transporter blockade and α-2 antagonism on blood pressure in autonomic failure.
    Okamoto LE; Shibao C; Gamboa A; Choi L; Diedrich A; Raj SR; Black BK; Robertson D; Biaggioni I
    Hypertension; 2012 Mar; 59(3):650-6. PubMed ID: 22311903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of yohimbine-induced renin release in the conscious rat.
    Pfister SL; Keeton TK
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jan; 337(1):35-46. PubMed ID: 3285225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of yohimbine on sympathetic responsiveness in essential hypertension.
    Damase-Michel C; Tran MA; Llau ME; Chollet F; Senard JM; Guiraud-Chaumeil B; Montastruc JL; Montastruc P
    Eur J Clin Pharmacol; 1993; 44(2):199-201. PubMed ID: 8453967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers.
    Grossman E; Rea RF; Hoffman A; Goldstein DS
    Am J Physiol; 1991 Jan; 260(1 Pt 2):R142-7. PubMed ID: 1847020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of yohimbine on release of anterior pituitary hormones.
    Goldberg MR; Jackson RV; Krakau J; Island DP; Robertson D
    Life Sci; 1986 Aug; 39(5):395-8. PubMed ID: 3016439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?
    Wu RA; Kailasam MT; Cervenka JH; Parmer RJ; Kennedy BP; Ziegler MG; O'Connor DT
    J Hypertens; 1994 Nov; 12(11):1243-7. PubMed ID: 7868871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alpha 2-adrenoreceptor regulation in the human body].
    Robertson D; Onrot J; Biaggioni I; Hollister A
    Kardiologiia; 1986 Jan; 26(1):15-20. PubMed ID: 3005749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrarenal contributions to indapamide's antihypertensive mechanism of action.
    Noveck RJ; McMahon FG; Quiros A; Giles T
    Am Heart J; 1983 Jul; 106(1 Pt 2):221-9. PubMed ID: 6869204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma catecholamines, platelet aggregation and associated thromboxane formation after physical exercise, smoking or norepinephrine infusion.
    Siess W; Lorenz R; Roth P; Weber PC
    Circulation; 1982 Jul; 66(1):44-8. PubMed ID: 7044612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular reactivity to mental stress is not affected by alpha2-adrenoreceptor activation or inhibition.
    Philippsen C; Hahn M; Schwabe L; Richter S; Drewe J; Schachinger H
    Psychopharmacology (Berl); 2007 Feb; 190(2):181-8. PubMed ID: 17111173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.